Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
dc.contributor.author | AbdelKhalek, Ahmed | en |
dc.contributor.author | Abutaleb, Nader S. | en |
dc.contributor.author | Mohammad, Haroon | en |
dc.contributor.author | Seleem, Mohamed N. | en |
dc.date.accessioned | 2020-09-21T16:11:32Z | en |
dc.date.available | 2020-09-21T16:11:32Z | en |
dc.date.issued | 2018-06-28 | en |
dc.date.updated | 2020-09-21T16:11:28Z | en |
dc.description.abstract | Enterococci represent one of the microbial world’s most challenging enigmas. Colonization of the gastrointestinal tract (GIT) of high-risk/immunocompromised patients by enterococci exhibiting resistance to vancomycin (VRE) can lead to life-threating infections, including bloodstream infections and endocarditis. Decolonization of VRE from the GIT of high-risk patients represents an alternative method to suppress the risk of the infection. It could be considered as a preventative measure to protect against VRE infections in high-risk individuals. Though multiple agents (ramoplanin and bacitracin) have been evaluated clinically, no drugs are currently approved for use in VRE decolonization of the GIT. The present study evaluates ebselen, a clinical molecule, for use as a decolonizing agent against VRE. When evaluated against a broad array of enterococcal isolates in vitro, ebselen was found to be as potent as linezolid (minimum inhibitory concentration against 90% of clinical isolates tested was 2 μg/ml). Though VRE has a remarkable ability to develop resistance to antibacterial agents, no resistance to ebselen emerged after a clinical isolate of vancomycin-resistant E. faecium was serially-passaged with ebselen for 14 days. Against VRE biofilm, a virulence factor that enables the bacteria to colonize the gut, ebselen demonstrated the ability to both inhibit biofilm formation and disrupt mature biofilm. Furthermore, in a murine VRE colonization reduction model, ebselen proved as effective as ramoplanin in reducing the bacterial shedding and burden of VRE present in the fecal content (by > 99.99%), cecum, and ileum of mice. Based on the promising results obtained, ebselen warrants further investigation as a novel decolonizing agent to quell VRE infection. | en |
dc.description.version | Published version | en |
dc.format.extent | 14 page(s) | en |
dc.format.medium | Electronic-eCollection | en |
dc.format.mimetype | application/pdf | en |
dc.identifier | ARTN e0199710 (Article number) | en |
dc.identifier.doi | https://doi.org/10.1371/journal.pone.0199710 | en |
dc.identifier.eissn | 1932-6203 | en |
dc.identifier.issn | 1932-6203 | en |
dc.identifier.issue | 6 | en |
dc.identifier.orcid | Seleem, Mohamed [0000-0003-0939-0458] | en |
dc.identifier.other | PONE-D-18-09775 (PII) | en |
dc.identifier.pmid | 29953486 (pubmed) | en |
dc.identifier.uri | http://hdl.handle.net/10919/100023 | en |
dc.identifier.volume | 13 | en |
dc.language.iso | en | en |
dc.publisher | PLoS | en |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | INDUCED HEARING-LOSS | en |
dc.subject | QUINUPRISTIN-DALFOPRISTIN | en |
dc.subject | STAPHYLOCOCCAL INFECTIONS | en |
dc.subject | CLOSTRIDIUM-DIFFICILE | en |
dc.subject | COLONIZED PATIENTS | en |
dc.subject | DOUBLE-BLIND | en |
dc.subject | FAECIUM | en |
dc.subject | MECHANISMS | en |
dc.subject | MANAGEMENT | en |
dc.subject | EMERGENCE | en |
dc.subject.mesh | Animals | en |
dc.subject.mesh | Mice | en |
dc.subject.mesh | Biofilms | en |
dc.subject.mesh | Enterococcus faecium | en |
dc.subject.mesh | Gram-Positive Bacterial Infections | en |
dc.subject.mesh | Organoselenium Compounds | en |
dc.subject.mesh | Azoles | en |
dc.subject.mesh | Virulence Factors | en |
dc.subject.mesh | Vancomycin Resistance | en |
dc.subject.mesh | Female | en |
dc.title | Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE) | en |
dc.title.serial | PLOS ONE | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.other | Article | en |
dc.type.other | Journal | en |
dcterms.dateAccepted | 2018-06-12 | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine | en |
pubs.organisational-group | /Virginia Tech/Faculty of Health Sciences | en |
pubs.organisational-group | /Virginia Tech/All T&R Faculty | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine/Biomedical Sciences and Pathobiology | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine/CVM T&R Faculty | en |
pubs.organisational-group | /Virginia Tech | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).pdf
- Size:
- 1.8 MB
- Format:
- Adobe Portable Document Format